Adial (@AdialPharma) header
Adial (@AdialPharma) profile picture

Adial (NASDAQ: $ADIL) is focused on developing therapies for the treatment and prevention of #addiction and related disorders.

Joined August 2017
Photo by Adial (@AdialPharma)Photo by Adial (@AdialPharma)Photo by Adial (@AdialPharma)Photo by Adial (@AdialPharma)Photo by Adial (@AdialPharma)Photo by Adial (@AdialPharma)Photo by Adial (@AdialPharma)Photo by Adial (@AdialPharma)Photo by Adial (@AdialPharma)Photo by Adial (@AdialPharma)
.@AdialPharma expanded its executive leadership team with Matthew Davidson as CDO and Julie Saiki as EVP of strategy, and closed the first $32M tranche of its previously announced up to $64M private placement. More here: bit.ly/4viADMm $ADIL #Biotech #PIPEFinancing #CorporateDevelopment
1
3
360
.@AdialPharma announced the acquisition of @AzoraTx, bringing AT177, a colon-targeted AhR agonist, into its pipeline. The transaction is supported by a concurrent private placement of up to $64M, including $32M upfront and potential additional milestone tranches. Adial will host a call and webcast today, June 11, 2026, at 1:00 pm ET to discuss the acquisition and financing. Dial-in: 1-877-451-6152 domestic / 1-201-389-0879 international; passcode 13761153. Webcast: bit.ly/4ejzOf5 Read more: bit.ly/3Q8x0cB $ADIL #Acquisition #PrivatePlacement #CorporateDevelopment
1
2
3
168
A major gap in alcohol use care: diagnosis. Reporting from bit.ly/2WArwY2 highlights @NIH-backed research in @JournalGIM showing many with unhealthy alcohol use go undiagnosed—and treatment rates remain low. Read more: bit.ly/4tkZ8YQ bit.ly/4a6LyiM #PublicHealth #AddictionMedicine #ClinicalResearch
1
1
270
What’s ahead for biopharma in 2026? In @PharmaScrip’s Scrip Asks series by @Citeline, leaders weigh in on capital allocation and deal activity shaping the industry’s future. $ADIL’s CEO Cary Claiborne shares his perspective: bit.ly/49yHJ5Q #Biopharma #Biotech #CapitalMarkets
1
174
Talking to someone about Alcohol Use Disorder (#AUD) isn’t easy—but words matter. Phrases like “why can’t you just stop?” can add shame instead of support. Empathy and understanding go further. Read more via @EverydayHealth: bit.ly/44HqptK #AlcoholAwareness #MentalHealth
1
78
Alcohol-related deaths have surged 89% over the past 25 years. The steepest increases? Women ages 25–34 and minority communities. It’s a reminder that AUD is a medical condition and not a moral failing. Read more via @PsychToday: bit.ly/4paSyRh #AlcoholAwareness #HolidayHealth
3
91
Alcohol use among women is rising—and so are the risks. At lower levels of drinking, women face a higher risk of liver disease, heart issues, brain effects, and breast cancer. Learn more via @NIAAAnews: bit.ly/3M8mKhU $ADIL #WomensHealth #HarmReduction
2
169
.@AdialPharma reports 2026 first quarter financial results and provides business update. bit.ly/3PaA2g0 $ADIL
1
1
140
Alcohol’s effects go beyond the moment: it can interfere with sleep, increase insomnia, and contribute to impaired-driving fatalities in the U.S. Read @AdialPharma’s infographic that shows why scalable, harm-reduction solutions matter now more than ever: bit.ly/3HvunNy $ADIL #HarmReduction #PublicHealth
2
76
Alcohol misuse carries a $249B annual burden in the U.S., with lost workplace productivity making up the majority of the cost. Our @AdialPharma infographic unpacks the economic impact and highlights the need for more effective harm-reduction approaches. bit.ly/3HvunNy $ADIL #HarmReduction #PublicHealth #AddictionAwareness
1
3
128
.@PsychTimes reports @AdialPharma has submitted AD04 to the @US_FDA’s National Priority Voucher Pilot Program, designed to accelerate review of therapies addressing critical public health needs. Read more: bit.ly/3Pa5TgB $ADIL #AlcoholUseDisorder #Biotech #ClinicalTrials #PrecisionMedicine #AddictionTreatment #PublicHealth
1
3
566
.@AdialPharma announced the filing of a new U.S. utility patent application with @uspto directed to AD04, its lead investigational genetically targeted therapeutic agent for #AUD in heavy-drinking patients. The application targets patient populations with heightened responsiveness to ondansetron and includes a Track One Prioritized Examination request to support a shorter review timeline and earlier patentability insights. If granted, the patent is expected to protect core assets through 2045 and reinforce Adial’s precision-medicine approach: bit.ly/4tBDLlD $ADIL #IntellectualProperty #PrecisionMedicine #AlcoholUseDisorder
1
1
131
.@AdialPharma submitted AD04 for consideration under the @US_FDA Commissioner’s National Priority Voucher Pilot Program, with an application focused on AUD as a major driver of the U.S. substance use crisis and AD04’s genetically targeted approach as a potential treatment option. For more: bit.ly/4vWaxiY $ADIL #AlcoholUseDisorder #PrecisionMedicine #AddictionTreatment
1
1
1
161
.@AdialPharma announced the successful completion of demonstration batch production for AD04, achieving all prespecified test specifications for dissolution, content uniformity and blend uniformity. This milestone enables production of the clinical and registration batches required for Adial’s planned Phase 3 clinical program and supports updates to the IND for AD04 with the @US_FDA. Read more: bit.ly/4d041QA $ADIL #ClinicalTrials #Manufacturing #DrugDevelopment
1
1
2
151
In a @FoxNews article by @atstabile, health experts noted that alcohol risk is highly individual as 40% of adults reported plans to drink less in 2026. @AdialPharma supports evidence-based, non-abstinence approaches to #AUD that are focused on reducing heavy drinking days. fxn.ws/3O7LyrQ #AUD #PrecisionMedicine #PublicHealth #Biotech
1
1
1
105
On the @BigBizShow, Cary Claiborne, CEO of @AdialPharma, discusses its precision medicine approach to #AUD, including a biomarker-driven therapy that targets a specific patient subgroup and helps reduce cravings through the brain’s reward system. Watch: bigbizshow.com/2026/02/12/ca… On YouTube: youtube.com/watch?v=xl5mj4r6… Available on @Roku, @AppleTV, @amazonfiretv, and @iHeartMedia, with distribution via @FoxBusiness, @NBCUniversal, and Time Warner Cable. $ADIL #AddictionTreatment #PrecisionMedicine #AI #MentalHealth
1
1
1
125
In our Spotlight Series, @AdialPharma reviews evidence supporting step-down reductions and harm reduction and explains why fewer heavy drinking days can translate into meaningful health and quality-of-life gains. Read more: bit.ly/4v0N3bV $ADIL #AlcoholUseDisorder #HarmReduction #AddictionMedicine #BehavioralHealth
1
329
How much alcohol is too much for men? @NYTimes health reporter @RoniNYTimes explores why guidelines are moving away from fixed limits. The takeaway aligns with Adial’s focus: Alcohol risk varies by individual, underscoring the need for more personalized approaches to AUD. Read more: nyti.ms/4s5vxRi #AUD #PrecisionMedicine #PublicHealth #MensHealth
2
1
1
136
.@AdialPharma CEO Cary Claiborne Sr. joined The BioHub Podcast to discuss AD04, a genetics-informed approach to #AUD, along with the realities of leading a micro-cap biotech and building in one of healthcare’s most complex disease areas. Watch/listen: YouTube: bit.ly/4cG35kY iTunes Podcast: apple.co/4bxTZFI #AlcoholUseDisorder #PrecisionMedicine #AddictionTreatment #ClinicalTrials
1
1
1
195
.@AdialPharma CEO Cary Claiborne was in Washington, D.C., meeting with House and Senate offices, including @bmhsudtf leadership. Conversations focused on behavioral health policy priorities and the need for evidence-based options for people living with Alcohol Use Disorder (#AUD). $ADIL #MentalHealth #AlcoholUseDisorder #BehavioralHealth #PublicPolicy
2
1
1
2
206